Publications | Flatiron Health | Lung cancer

Browse every publication tagged Lung cancer

May 2026
Comparison of real-world overall survival between atezolizumab- and durvalumab-containing first- line induction and maintenance regimens in extensive-stage small cell lung cancer
- Comparative effectiveness
- Lung cancer
May 2026
Drivers of organotropism and patterns of metastatic progression in metastatic non-small cell lung cancer
- Lung cancer
May 2026
Digital twin models for counterfactual prediction in NSCLC: a validation study using clinical trial data
- Artificial intelligence
- Lung cancer
May 2026
Machine learning risk stratification in a US-based database to identify subgroups of patients with PD-L1-high NSCLC who benefit from adding chemotherapy to pembrolizumab
May 2026
External validation of a deep learning CT biomarker to predict first-line immune checkpoint inhibitor monotherapy-associated survival in PD-L1–high metastatic non–small cell lung cancer
May 2026
Real-world second-line treatment patterns and outcomes by platinum sensitivity in extensive-stage small cell lung cancer in the post-immunotherapy era
- Lung cancer
- Treatment and Testing patterns
May 2026
A risk stratification schema for patients with non-small cell lung cancer with multiple organ metastases
- Lung cancer
April 2026
Using regression discontinuity in time to strengthen real-world evidence: a case study in lung cancer
- Methodology
- Lung cancer
April 2026
Impact of telemedicine encounters on survival outcomes in advanced lung cancer: A time-varying cox analysis using EHR-derived data
- Lung cancer